| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.09 | 0.03 |